JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Scope & Guideline

Connecting Insights in Peripheral Nerve Pathophysiology

Introduction

Delve into the academic richness of JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM with our guidelines, detailing its aims and scope. Our resource identifies emerging and trending topics paving the way for new academic progress. We also provide insights into declining or waning topics, helping you stay informed about changing research landscapes. Evaluate highly cited topics and recent publications within these guidelines to align your work with influential scholarly trends.
LanguageEnglish
ISSN1085-9489
PublisherWILEY
Support Open AccessNo
CountryUnited Kingdom
TypeJournal
Convergefrom 1996 to 2024
AbbreviationJ PERIPHER NERV SYST / J. Peripher. Nerv. Syst.
Frequency4 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address111 RIVER ST, HOBOKEN 07030-5774, NJ

Aims and Scopes

The Journal of the Peripheral Nervous System focuses on advancing the understanding of peripheral nervous system disorders through rigorous research and innovative methodologies. It serves as a platform for sharing significant findings across a broad spectrum of topics related to peripheral neuropathies, including genetic, clinical, electrophysiological, and therapeutic aspects.
  1. Genetic and Molecular Mechanisms:
    Research exploring the genetic underpinnings and molecular mechanisms of peripheral neuropathies, particularly focusing on inherited conditions like Charcot-Marie-Tooth disease and hereditary transthyretin amyloidosis.
  2. Clinical Characterization and Diagnostics:
    Studies aimed at improving the clinical diagnosis and characterization of peripheral neuropathies, including the use of advanced imaging techniques, nerve conduction studies, and biomarker identification.
  3. Therapeutic Interventions and Clinical Trials:
    Investigations into therapeutic strategies for managing peripheral neuropathies, encompassing pharmacological treatments, gene therapy, and clinical trial outcomes.
  4. Pathophysiology of Neuropathies:
    Research aimed at understanding the pathophysiological changes in peripheral nerve diseases, including inflammatory, autoimmune, and metabolic aspects.
  5. Neuropathic Pain Management:
    Studies focusing on the mechanisms and treatment of neuropathic pain associated with various peripheral nerve disorders.
  6. Innovative Diagnostic Techniques:
    Development and validation of novel diagnostic tools, such as ultrasonography and machine learning approaches, to enhance the assessment of peripheral nerve conditions.
The Journal of the Peripheral Nervous System has identified several emerging themes that reflect current trends and advancements in the field, demonstrating a shift towards innovative research methodologies and clinical applications.
  1. Machine Learning and AI in Neuropathy Diagnosis:
    There is a growing trend towards utilizing machine learning and artificial intelligence to improve diagnostic accuracy and patient outcomes in peripheral neuropathies.
  2. Biomarker Discovery and Application:
    Research focused on identifying and validating biomarkers for various neuropathies is on the rise, enhancing diagnostic capabilities and treatment monitoring.
  3. Telemedicine and Remote Monitoring:
    The use of telemedicine and digital health technologies for monitoring and managing peripheral neuropathies has gained traction, particularly in response to the COVID-19 pandemic.
  4. Multi-Omics Approaches:
    Emerging studies employing multi-omics techniques (genomics, proteomics, metabolomics) to better understand the complex biology of peripheral nerve disorders are increasingly prevalent.
  5. Patient-Centered Outcomes and Quality of Life:
    Research emphasizing the impact of peripheral neuropathies on quality of life and the development of patient-reported outcome measures is becoming more prominent.

Declining or Waning

While the journal continues to publish a diverse range of articles, certain topics have seen a decrease in frequency and may indicate waning interest or development in those areas.
  1. Chemical and Environmental Neuropathy:
    Research focusing on chemical-induced neuropathies, such as those related to environmental toxins or specific chemotherapy agents, has become less frequent as a focus area.
  2. Epidemiological Studies of Rare Neuropathies:
    Epidemiological research on rare peripheral neuropathies is declining, possibly due to the increasing focus on more prevalent conditions and the need for robust data in clinical settings.
  3. Basic Animal Model Studies:
    There appears to be a reduction in studies solely based on basic animal models of peripheral neuropathies, as the focus shifts towards translational research that can directly inform clinical practice.
  4. Socioeconomic Impact Studies:
    The frequency of studies examining the socioeconomic impacts of peripheral neuropathies on patient populations has diminished, possibly overshadowed by more clinically relevant research.
  5. Historical Perspectives on Neuropathy:
    Articles providing historical context or retrospective analyses of neuropathies are appearing less frequently, reflecting a shift towards contemporary research and clinical applications.

Similar Journals

Pain Research & Management

Empowering Clinicians with Cutting-edge Pain Research
Publisher: HINDAWI LTDISSN: 1203-6765Frequency:

Pain Research & Management, published by HINDAWI LTD, is a leading academic journal that serves as a vital resource for researchers, clinicians, and students in the fields of anesthesiology, pain medicine, and neurology. With an impressive impact factor and categorized in the second quartile (Q2) for both anesthesiology and neurology as of 2023, the journal features high-quality, peer-reviewed research articles that address the complexities of pain management. Established in 1996 and recognized as Open Access, this journal allows unrestricted access to groundbreaking studies, thereby facilitating knowledge dissemination and collaboration within the global scientific community. With a strong ranking—34/136 in anesthesiology and 72/192 in neurology—Pain Research & Management retains a well-deserved reputation for publishing innovative and authoritative content that significantly contributes to the advancement of pain research and clinical practice. Researchers and healthcare professionals alike will find this journal indispensable for staying abreast of the latest discoveries and best practices in pain management.

ASN Neuro

Pioneering Research for a Deeper Understanding of the Nervous System
Publisher: FRONTIERS MEDIA SAISSN: 1759-0914Frequency: 1 issue/year

ASN Neuro is an esteemed academic journal published by Frontiers Media SA, focusing on critical advancements in the fields of neurology and neuroscience. Since its inception in 2009, it has established itself as an Open Access platform dedicated to fostering the dissemination of knowledge and research findings that address the complexities of the nervous system. With an impressive impact factor and consistently ranking in the top quartiles of its categories—Q1 in Neurology (clinical) and Q2 in Neuroscience (miscellaneous)—ASN Neuro is recognized for its high-quality publications that cater to the evolving challenges in clinical neurology and general neuroscience. Currently, it ranks 68th out of 400 journals in Clinical Neurology and 28th out of 113 in General Neuroscience, affirming its reputable position within the academic community. Researchers, professionals, and students alike are encouraged to contribute to and benefit from this impactful journal as it presents a unique opportunity to engage with cutting-edge research, innovative methodologies, and insightful reviews in the ever-evolving landscape of brain science.

NEUROSCIENTIST

Advancing the Frontiers of Neurological Science
Publisher: SAGE PUBLICATIONS INCISSN: 1073-8584Frequency: 6 issues/year

NEUROSCIENTIST is a leading journal in the field of clinical neurology and neuroscience, published by SAGE Publications Inc. With an impressive impact factor reflected in its Q1 quartile ranking in both clinical neurology and miscellaneous neuroscience as of 2023, this journal positions itself as a crucial platform for the latest research and advancements in the neural sciences. Spanning from 1995 to 2024, NEUROSCIENTIST features a range of high-quality, peer-reviewed articles that cater to researchers, practitioners, and students alike. Although it does not offer Open Access options, the journal remains a vital resource owing to its Scopus rankings, situating it within the top percentile of its categories: ranked #28 out of 400 in clinical neurology and #15 out of 113 in general neuroscience. The journal's commitment to disseminating significant findings underlines its importance in fostering advancements in neurological understanding and treatment.

Frontiers in Neuroscience

Pioneering discoveries in the realm of neuroscience.
Publisher: FRONTIERS MEDIA SAISSN: Frequency: 1 issue/year

Frontiers in Neuroscience, published by FRONTIERS MEDIA SA, is a premier open-access journal dedicated to advancing our understanding of the nervous system through innovative and rigorous research. Since its inception in 2007, this journal has become an influential platform for researchers, featuring a diverse range of topics across various subfields of neuroscience. With its current ranking in the second quartile (Q2) of the category "Neuroscience (miscellaneous)" and a commendable position of #40 out of 113 in general neuroscience according to Scopus, Frontiers in Neuroscience is recognized for its high-impact contributions. The journal promotes free access to scholarly work, ensuring that cutting-edge neuroscience studies reach a global audience and foster collaboration across disciplines. By bridging gaps in knowledge and facilitating the exchange of ideas, Frontiers in Neuroscience plays a pivotal role in addressing the complexities of the nervous system and its effects on behavior, cognition, and health.

Journal of Central Nervous System Disease

Connecting clinical insights with molecular breakthroughs.
Publisher: SAGE PUBLICATIONS LTDISSN: 1179-5735Frequency: 1 issue/year

Welcome to the Journal of Central Nervous System Disease, a premier Open Access publication dedicated to advancing the understanding of neurological disorders and their underlying mechanisms. Published by SAGE Publications Ltd, this esteemed journal has been serving the scientific community since 2009 and is committed to disseminating high-quality research that spans from clinical neurology to cellular and molecular neuroscience. With an impressive impact factor, the journal ranks within the top quartiles—Q2 in both Neurology and Clinical Neurology, and Q3 in Cellular and Molecular Neuroscience as of 2023. The journal's indexing in Scopus reflects its significant contribution to the field, being ranked #83 out of 400 in clinical neurology and #38 out of 97 in cellular and molecular neuroscience. This essential resource, based in the United States, is crucial for researchers, clinicians, and students looking to stay at the forefront of neurological science. By providing Open Access options, we ensure that groundbreaking research is readily available to a global audience, fostering collaboration and innovation in the study of central nervous system diseases.

Journal of Brachial Plexus and Peripheral Nerve Injury

Connecting clinicians and researchers in neurology.
Publisher: THIEME MEDICAL PUBL INCISSN: 1749-7221Frequency:

The Journal of Brachial Plexus and Peripheral Nerve Injury, published by THIEME MEDICAL PUBL INC, is a leading open-access journal dedicated to the field of neurology, specifically focusing on injuries related to the brachial plexus and peripheral nerves. Since its inception in 2006, the journal has provided a platform for researchers, clinicians, and students to share cutting-edge studies and advancements within this specialized area of neurology. With an impact factor that underscores its relevance in the academic community, the journal is categorized in the Q4 quartile for both Neurology and Clinical Neurology in 2023. The journal aims to foster collaboration and innovation among professionals by presenting rigorous research findings, clinical studies, and reviews that enhance the understanding and management of nerve injuries. Published from the United Kingdom, the journal facilitates global access to important knowledge, encouraging contributions that will further the discourse in this critical field of medicine.

NEUROIMMUNOMODULATION

Advancing Understanding of Neural-Immune Interactions
Publisher: KARGERISSN: 1021-7401Frequency: 4 issues/year

NEUROIMMUNOMODULATION is a well-respected journal published by KARGER that focuses on the intricate interactions of the nervous and immune systems. With its ISSN 1021-7401 and E-ISSN 1423-0216, it serves as a vital resource for researchers and professionals interested in neuroimmunology and related fields. The journal has been committed to disseminating high-quality research from its inception in 1994 and continues to thrive, with its scope converged until 2024. Notably, it holds a Q3 ranking in 2023 across diverse categories such as Endocrine and Autonomic Systems, Endocrinology, Immunology, and Neurology, reflecting its significance in the scientific community. Although the journal is not open access, it remains an essential publication for advancing knowledge and fostering collaboration among scholars, making it a noteworthy source of cutting-edge findings in the complex interplay between neural and immune processes.

RESTORATIVE NEUROLOGY AND NEUROSCIENCE

Advancing Neural Restoration: Pioneering Research in Neurology and Neuroscience
Publisher: IOS PRESSISSN: 0922-6028Frequency: 6 issues/year

RESTORATIVE NEUROLOGY AND NEUROSCIENCE, published by IOS PRESS, is a premier journal dedicated to advancing the fields of neurology and neuroscience. Since its inception in 1989, this journal has played a crucial role in disseminating cutting-edge research findings and innovative therapeutic approaches that aim to restore neurological function and improve patient outcomes. With a focus on developmental neuroscience and clinical neurology, the journal holds a 2023 Scopus ranking of #129 out of 400 in clinical neurology, and #15 out of 37 in developmental neuroscience, reflecting its significant influence in these domains. Although it operates on a non-open access model, RESTORATIVE NEUROLOGY AND NEUROSCIENCE offers valuable insights for researchers, healthcare professionals, and students seeking to deepen their understanding of neural restoration mechanisms and therapeutic strategies. Located in Amsterdam, Netherlands, the journal continues to foster scholarly dialogue and innovation, contributing to the global advancement of neuroscience and neurology.

JOURNAL OF NEUROIMMUNOLOGY

Advancing Insights in Neuroimmune Science
Publisher: ELSEVIERISSN: 0165-5728Frequency: 12 issues/year

JOURNAL OF NEUROIMMUNOLOGY is a premier academic journal dedicated to exploring the intricate interactions between the nervous and immune systems. Published by Elsevier, this journal has been at the forefront of neuroimmunology research since its inception in 1981 and continues to disseminate high-quality, peer-reviewed articles that are critical for advancing understanding in the fields of immunology, neurology, and neuroscience. With an impressive impact factor and a Q2 ranking in multiple categories including Neurology and Immunology and Allergy, it serves as an essential resource for researchers, clinicians, and students alike who seek to deepen their knowledge of the neuroimmune landscape. The journal’s rigorous selection process ensures that only the most relevant and impactful research is published, fostering a vibrant academic discourse and facilitating knowledge transfer among professionals in the field. Although the journal is not open access, its contributions to both therapeutic insights and foundational research make it a valuable asset for those committed to the advancement of neuroimmunological science.

Pain Practice

Bridging Science and Practice in Pain Relief
Publisher: WILEYISSN: 1530-7085Frequency: 8 issues/year

Pain Practice is an esteemed journal published by WILEY, focusing on the vital field of Anesthesiology and Pain Medicine. With an impressive impact factor reflected in its ranking of #30 out of 136 in its category, Pain Practice operates within the Q2 quartile, indicating its significant influence and contribution to research and clinical practices in managing pain. Established in 2004 and set to converge in 2024, this journal is dedicated to publishing high-quality, peer-reviewed articles that cover a wide range of topics related to pain management, therapeutic approaches, and novel interventions. Although it does not currently offer open access, it remains a crucial resource for professionals and researchers in the field, encouraging advancements in treatment methods and enhancing patient care in pain management.